Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,085 total articles

Viasat Releases Fourth Quarter and Fiscal Year 2026 Financial Results

Viasat Releases Fourth Quarter and Fiscal Year 2026 Financial Results

Viasat, Inc., a global satellite communications company, announced its financial results for the fourth quarter and fiscal year 2026. The company provides a live webcast and conference call to discuss the financial details. The release highlights Viasat's recent strategic acquisition of Inmarsat, reinforcing its position in the global communication…

Runway Growth Finance Corp. Prices Offering of 7.00% Notes due 2029

Runway Growth Finance Corp. Prices Offering of 7.00% Notes due 2029

Runway Growth Finance Corp. announced the pricing of an underwritten public offering of $50 million aggregate principal amount of 7.00% notes due December 1, 2029. Net proceeds of approximately $48.4 million will be used primarily to repay outstanding indebtedness under its Credit Facility as well as for general corporate purposes. The notes will p…

Wealthfront Executives to Present at Upcoming Investor Conferences

Wealthfront Executives to Present at Upcoming Investor Conferences

Wealthfront Corporation announced that its top executives, including CEO David Fortunato and CFO Alan Imberman, will present at the RBC Capital Markets Global Financial Technology Conference and the Morgan Stanley US Financials Conference in June 2026. The presentations will be available via live webcast on the company's investor relations website.

Netcapital Acquires Assets to Accelerate AI-Powered Strategy

Netcapital Acquires Assets to Accelerate AI-Powered Strategy

Netcapital Inc. has acquired the NetNudge AI Agent Platform assets from Codesharp Corporation to expand its AI-powered solutions in private capital markets. The acquisition supports Netcapital's strategy to leverage its regulatory infrastructure and deliver scalable AI-enabled tools and services, including operational intelligence and workflow auto…

Asure Software Expands Strategic Partnership with FRPG Restaurant Rewards to Deliver Comprehensive HR, Payroll, and Workforce Solutions to Independent Restaurant Operators Nationwide

Asure Software Expands Strategic Partnership with FRPG Restaurant Rewards to Deliver Comprehensive HR, Payroll, and Workforce Solutions to Independent Restaurant Operators Nationwide

Asure Software expands its strategic partnership with FRPG Restaurant Rewards, a large GPO serving independent restaurants, to enhance distribution and offer comprehensive cloud-based HR, payroll, and workforce management solutions tailored for the independent restaurant sector. This move aims to help independent restaurants manage labor costs, com…

New Era Energy & Digital Announces Agreement for Dismissal of All Claims Against the Company by the State of New Mexico

New Era Energy & Digital Announces Agreement for Dismissal of All Claims Against the Company by the State of New Mexico

New Era Energy & Digital, Inc. announced a pending settlement agreement that would result in the dismissal of the company's claims in a lawsuit filed by the State of New Mexico. The agreement includes a $1 million payment to the bankruptcy trustee and explicitly denies liability. The company remains focused on developing its large-scale AI data cen…

Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy

Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy

Emergent BioSolutions Inc. has secured a $64.5 million contract modification from the U.S. Department of Health and Human Services to provide Botulism Antitoxin Heptavalent (BAT®) as part of its ongoing biodefense supply efforts. The contract supports treatment against botulinum neurotoxin exposure and highlights Emergent's role in national health …

Apogee Therapeutics to Participate in Upcoming June Conferences

Apogee Therapeutics to Participate in Upcoming June Conferences

Apogee Therapeutics announced that its management will participate in upcoming Jefferies and Goldman Sachs global healthcare conferences in June 2026, highlighting its clinical-stage biotech developments in immunology and inflammation disease treatments. The company focuses on novel biologics targeting atopic dermatitis, asthma, eosinophilic esopha…

Outlook Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Outlook Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Outlook Therapeutics, a biopharmaceutical company developing ophthalmic formulations for retinal diseases, has priced a $5.0 million at-the-market registered direct offering of 8.5 million shares to its largest shareholder, GMS Ventures and Investments. The proceeds will be used for working capital and general corporate purposes. Additionally, the …

Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak

Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak

Regeneron Pharmaceuticals announced that the World Health Organization's Therapeutics Advisory Group has recommended prioritizing evaluation of maftivimab, a potent antibody component of its Ebola treatment Inmazeb, for investigational use against the current Bundibugyo ebolavirus outbreak in the Democratic Republic of Congo and Uganda. Inmazeb is …

Brandywine Realty Trust Announces Common Quarterly Dividend, and Confirms Second Quarter 2026 Earnings Release and Conference Call

Brandywine Realty Trust Announces Common Quarterly Dividend, and Confirms Second Quarter 2026 Earnings Release and Conference Call

Brandywine Realty Trust announced a quarterly dividend of $0.08 per share payable on July 22, 2026, and confirmed the release of its second quarter 2026 earnings on the same day, followed by a conference call on July 23, 2026. The company is a major US real estate investment trust focused mainly on Philadelphia and Austin.

Husky Technologies Appoints Mohammad Kanaan as Chief Financial Officer and Karen Stone as Chief Human Resources Officer

Husky Technologies Appoints Mohammad Kanaan as Chief Financial Officer and Karen Stone as Chief Human Resources Officer

GPGI, Inc., a company traded on the NYSE under ticker GPGI, announced key leadership appointments at its Husky Technologies business. Mohammad Kanaan has been named Chief Financial Officer and Karen Stone Chief Human Resources Officer, bringing extensive global experience to support Husky's growth and cultural transformation initiatives. These move…

Del Taco Brings Back Value Starting at Just $1

Del Taco Brings Back Value Starting at Just $1

Del Taco Restaurants, Inc. introduces a new nationwide "Get A Lot For What You’ve Got" value menu featuring over 10 items starting at just $1, including fan-favorite items and bundled meal deals. This initiative aims to provide affordable, high-quality options that appeal to today’s budget-minded customers without compromising on taste or freshness…

Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue

Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue

Tevogen Bio Holdings Inc. (Nasdaq: TVGN) announced progress in its strategic acquisition initiatives aimed at complementing its biotechnology and AI businesses. The planned acquisitions, including a contract research organization (CRO), could potentially produce approximately $100 million in combined annual revenue, supporting the company’s goal to…

Pemvidutide Demonstrates Significant Metabolic Improvements in Patients with MASH in New 48‑Week IMPACT Phase 2b Data Presented at EASL 2026

Pemvidutide Demonstrates Significant Metabolic Improvements in Patients with MASH in New 48‑Week IMPACT Phase 2b Data Presented at EASL 2026

Altimmune, Inc. announced promising 48-week data from its IMPACT Phase 2b trial demonstrating that pemvidutide, a novel glucagon/GLP-1 dual receptor agonist, significantly reduces triglycerides, cholesterol, weight, waist circumference, and blood pressure in patients with metabolic dysfunction-associated steatohepatitis (MASH). The drug also improv…

Blue Ops Ramps into Full-Rate Production of U.S.-Built Variant 7, Advancing Red Cat’s Autonomy Stack Across Air, Land and Sea

Blue Ops Ramps into Full-Rate Production of U.S.-Built Variant 7, Advancing Red Cat’s Autonomy Stack Across Air, Land and Sea

Red Cat Holdings announces ramp-up to full-rate production of the Variant 7, a U.S.-designed and built uncrewed surface vessel under its maritime division Blue Ops, aimed at defense and national security missions. The platform leverages U.S.-made components and modular architecture to ensure adaptability and compliance with government standards, al…

VPG to Participate in Investor Conferences in June 2026

VPG to Participate in Investor Conferences in June 2026

Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, announced its participation in two investor conferences in June 2026, including the Noble Capital Markets Emerging Growth Virtual Equity Conference and the 16th East Coast IDEAS Conference. The company will webcast its presentations and offer oppor…